Correlation between histopathological results and BI-RADS classification in breast masses

Histopathological Spectrum of Various Birads Categories of Breast Lesions- A Retrospective Study.

“…In a study by Nizamettin et al [6], 85.7% of malignant cases were in postmenopausal period, whereas 14.3% of them were in premenopausal period. Malignancy rate generally increased in patients over the age of 47yrs.…”

“…[Fig 1, 2] Nizamettin et al (2019) reported 96.43% concordance in BIRADS V lesions. [6]. Granulomatous mastitis can mimic breast carcinoma clinically and mammographically.…”

“…In a study by Nizamettin et al, the malignancy rate was 2.28% in BIRADS 4a, 2.86% 4b and 63.64% in 4c lesions. [6] Histopathological analysis of the discordant BIRADS Category IV cases showed , features , ranging from high grade DCIS(1 case), atypical ductal hyperplasia(3cases), FCC with Usual Ductal Hyperplasia (4 cases), Adenomatous h y p e r p l a s i a , E p i t h e l i o s i s a n d B e n i g n e p i t h e l i a l proliferation(4cases) , duct papilloma(2cases), 1 case of tubular adenoma, 1 case of periductal adenoma, 2 cases of mastitis . In the broad category of BIRADS IV, 37 cases concordant cases include malignant lesions like invasive duct cell carcinoma-NST and discordant cases include brocystic disease, broadenoma, tubular adenoma, intraductal papilloma, phyllodes tumour.…”

“…In a study by Nizammettin et al, the malignancy rate was 0 % in BIRADS-3 lesions. [6] Mentes et al determined the probability of malignancy in BIRADS-3 as 1.5% and 32.6% in BIRADS-4 lesions.…”

Correlação entre achados imagenológicos e histopatológicos de lesões não palpáveis de mama em pacientes atendidos em hospital de referência da Amazônia

“…Quanto aos resultados histopatológicos das lesões classificadas como BI-RADS® III, 33% das lesões eram malignas e 67% benignas em nossa casuística. No estudo de Kutluer N et al (2019), com 150 pacientes, evidenciou que 100% das lesões BI-RADS® III (n=21) foram benignas.…”